Google’s Verily Signs First Drug Discovery Pact With Sosei Heptares

Tech Company's Life Sciences Division Gaining Momentum

 
• By Andrew McConaghie

Efforts to map disease using big data computing and speed drug discovery are gathering pace, with Verily among a wave of life science-focused tech companies.

Verily , South San Francisco
Verily's impact on biopharma has been limited since it was set up in 2015, but the Alphabet company now looks to be gaining momentum. • Source: Alamy

More from Clinical Trials

More from R&D